Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone to help regulate appetite and blood sugar
Focus on protein options that satisfy without requiring large portions, or choose a soup and salad combination that gives you variety without excess
Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved Wegovy HD (once-weekly injectable semaglutide 7.2 mg) to reduce excess body weight and maintain weight reduction long-term
GLP-1 medications work by mimicking this hormones effects, making it easier for patients to control their appetite
Additionally, we evaluate and support patients experiencing neurological symptomssuch as numbness, tingling, cognitive changes, or peripheral neuropathywhen a B12 deficiency is suspected or confirmed through laboratory testing
A third patient mentioned losing 40 pounds after signing up in February, highlighting the platform role in providing affordable access to medication that transformed their weight loss trajectory